Italo Tempera

22PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersGenome structure and regulationMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 14, 2026
EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancers.

|Feb 10, 2026
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer.

Sarah Preston-Alp, Yin Wang, Matteo Bergonzoni

|Feb 06, 2026
Lamin A/C maintains genome topology and regulates transcriptional programs essential for virus-driven B cell activation.

Lisa B Caruso, Davide Maestri, Andrew Kossenkov

|Nov 28, 2025
The CTLH ubiquitin ligase substrates ZMYND19 and MKLN1 negatively regulate mTORC1 at the lysosomal membrane.

Yin Wang, Yifei Liao, Yizhe Sun

|Nov 24, 2025
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV associated gastric cancer.

Sarah Preston-Alp, Yin Wang, Matteo Bergonzoni

|Jul 14, 2025
Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenome.

Leonardo Josué Castro-Muñoz, Davide Maestri, Leena Yoon

Pageof 4

Frequent Collaborators

9 joint publications

Paul M Lieberman

4 joint publications

Benjamin Gewurz

2 joint publications

Hsin-Yao Tang

2 joint publications

Sarah Preston-Alp